Intercept Pharmaceuticals reported $-17543000 in Pre-Tax Profit for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US USD -40890000 14.48M
Alnylam Pharmaceuticals ALNY:US USD -207021000 122.34M
Amarin AMRN:US USD -3883000 60.92M
Amgen AMGN:US USD 2.54B 364M
Arrowhead Research ARWR:US USD -41794000 40.36M
AstraZeneca AZN:LN USD 2.29B 796M
Bluebird Bio BLUE:US USD -76513000 16.99M
Eli Lilly And LLY:US USD 2.04B 38.3M
Enanta Pharmaceuticals ENTA:US USD -29020000 2.69M
Esperion Therapeutics ESPR:US USD -55487000 370K
Galectin Therapeutics GALT:US USD -8597000 1.02M
Gilead Sciences GILD:US USD 2.52B 357M
GlaxoSmithKline GSK:LN GBP 1.36B 1.07B
Intercept Pharmaceuticals ICPT:US USD -17543000 86.54M
Moderna Inc MRNA:US USD 1.66B 438M
Neurocrine Biosciences NBIX:US USD 117.9M 20M
Novartis NOVN:VX USD 3.86B 195M
Ptc Therapeutics PTCT:US USD -156309000 29.1M
Regeneron Pharmaceuticals REGN:US USD 1.63B 188.9M
Sangamo Biosciences SGMO:US USD -51714000 1.41M
Sarepta Therapeutics SRPT:US USD -101306000 155.11M
Vertex Pharmaceuticals VRTX:US USD 1.2B 122.8M
YTE INCY:US USD 178.62M 401K